Experimental drug shows promise in clearing HIV from brain

Published Date: 31 Jul 2024

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.

Read Full News

Latest News

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Lenacapavir PrEP: No New HIV infections & High Satisfaction

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

Ebola Cases in Congo Exceed 5,000, Government Data Shows

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Kids With Complex Conditions Face Higher Antibiotic Exposure

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Doravirine Add-On Boosts Virologic Control in HIV Infection

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

WHO Says Congo Ebola Outbreak Can Still Be Brought Under Control Within Three Months

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

News All Time

Congo Reports Ebola Death in New Province, Official Says

Democratic Republic of Congo health authorities have identified a person who has died from Ebola ⁠in a province not previously affected by the ongoing outbreak, an official...

Once-Weekly Oral ART Matches Daily ART for Viral Suppression

The potential arrival of once-weekly oral ART options could be particularly important for those who face challenges of stigma or adherence difficulties, advocate says.

UK Regulator Endorses Safety Of Childhood Vaccination

Britain's health regulator on Wednesday reaffirmed the safety of ⁠childhood vaccination and endorsed it as an effective and safe way ⁠to safeguard against serious infectious...

Vaccination in Pregnancy Embraced by Ob/Gyns

Long the primary purview of pediatricians, routine discussion and administration of vaccines is an increasing focus of obstetric clinicians.

Controlled Breathing May Help Cut Addiction Cravings

Controlled breathing interventions are associated with reduced craving in patients with substance use disorders compared with control interventions, new research shows.

Encephalitis Linked to Long-Term Dementia Risk

Survivors of encephalitis face elevated dementia risk years later, with the magnitude varying by age and etiology, a study shows.

Meningococcal B Vaccine May Cut Gonorrhea Risk in Teens

A multicomponent meningococcal B vaccine showed modest protection against gonorrhea in a high-burden population, a study shows.

Australia to Vaccinate Vulnerable Native Birds Against Bird Flu

Australia will soon begin vaccinating its vulnerable native birds against the deadly H5N1 bird ⁠flu as the virus spreads more widely after first being detected in the...

New Transmission From Animals Likely Caused Congo-Uganda Ebola Outbreak, Study Says

The ongoing Ebola outbreak in Democratic Republic of Congo concerns a previously unseen ⁠variant of the rare Bundibugyo species of the virus, indicating it stemmed from a...

HIV Care Disengagement Common in Missouri

A pattern of cycling in and out of care challenges the linear depiction of the HIV care continuum, with implications for retention strategies in priority jurisdictions.

HIV and Hepatitis C Screening at Appalachian Music Festival

A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.

Roche Launches Two New Cyclospora Tests as US Outbreak Widens

Roche said on Thursday it launched two new tests to detect cyclospora, as ⁠U.S. cyclosporiasis cases climbed to record levels this year making the foodborne-illness outbreak...

Michigan Eases Lettuce Advice as State Health Department Says Cyclosporiasis Reports Decline

Michigan health officials on Thursday advised residents to resume eating lettuce and salad greens, citing a slowdown in new cyclosporiasis infections, after reporting...

US Will Nearly Double Financial Commitment to Ebola Response

The U.S. State Department on Wednesday nearly doubled its financial commitment to the Ebola response in eastern Democratic Republic of Congo, announcing ⁠plans to provide an...

US FDA Approves First MRNA Flu Shot From Moderna

The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval ⁠of a...

Baseline Steroids Fail to Benefit Bronchiectasis Patients

Observational data show an association between baseline inhaled corticosteroid use and poor outcomes after a year.

Recommended News For You

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

Oleanolic acid from grapes may increase chemotherapy effectiveness

Patients value communication skills from cancer surgeons across six key areas, according to research

Year in Review: Multiple Myeloma

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

New Zealand and Australian breast cancer rates among the highest in the world, global study finds

Recommended Articles For You

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer 

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

1.

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care

2.

Progressive Insights in Hematology in the Digital Era

3.

Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective

4.

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources

5.

The Rise of Immunotherapy: New Advances in Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

2.

Blood Clotting Disorders Explained

3.

Sickle Cell Disease Explained

4.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot